Stock Events

Stock Events

Silexion Therapeutics (SLXN) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-7.4

-4.97

-2.54

-0.11

Details

Expected EPS

-3.3

Actual EPS

-3.9

Surprise EPS

-0.6

Surprise Percent

+18.18%

Description

Silexion Therapeutics (SLXN) has reported earnings of -3.9 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.